Abstract

Objective: We sought to investigate the impact of gender on post-procedural outcomes of CAS and CEA in general practice at a national level. Background Data derived from Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) suggested differential comparative periprocedural benefit between CAS and CEA on basis of gender. Design/Methods: We analyzed the data from the Nationwide Inpatient Sample which is representative of all admissions from 2005-2009. The primary end point was occurrence of stroke, cardiac complications, or death during the post procedural period. Outcomes of interest were compared between men and women, undergoing CEA and CAS. Multivariate logistic regression was performed to determine the effect of gender on occurrence of post-operative stroke, cardiac complications, or death for CAS and CEA separately. Covariates included in the logistic regression were patient9s age, gender, co-morbid conditions including hypertension, diabetes mellitus, chronic lung disease, coronary artery disease etc. Results: Of the total 673,170 estimated patients, 591,543 (88%) underwent CEA and the remaining 81627 (12%) underwent CAS. There was no difference between men and women in post-operative stroke, cardiac complications, or death for women undergoing CAS for both symptomatic and asymptomatic status as well as symptomatic women undergoing CEA. Post operative strokes (0.99% vs 0.84%, p= 0.01) were higher in asymptomatic women however cardiac complications were higher for asymptomatic men (2.0% vs 1.64%, p= 0.0001) and composite end points was lower in women (2.80% vs 3.00%, p= 0.02) undergoing CEA. In multivariate analysis, gender was not a significant factor for composite end points among patients undergoing either CAS (RR, 95% CI) or CEA (RR, 95% CI) after adjusting for potential confounders. Conclusions: Our analysis suggests that postprocedural rate of events are not significantly different between men and women undergoing either CAS or CEA in general practice and should not be used to determine eligibility for either procedure. Disclosure: Dr. Khatri has nothing to disclose. Dr. Chaudhry has nothing to disclose. Dr. Watanabe has nothing to disclose. Dr. Jadhav has nothing to disclose. Dr. Hassan has nothing to disclose. Dr. Rodriguez has nothing to disclose. Dr. Suri has nothing to disclose. Dr. Qureshi has nothing to disclose.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.